ShanXi C&Y Pharmaceutical Group Co.,LTD. (SHE:300254)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Urinary System Drugs	198.17M
Urinary System Drugs Growth	20.06%
Anti-infective Drugs	166.45M
Anti-infective Drugs Growth	-6.15%
Pharmaceutical Raw Materials and Intermediates	80.41M
Pharmaceutical Raw Materials and Intermediates Growth	41.63%
Smoking Cessation Drugs	64.16M
Children's Drugs	60.80M
Children's Drugs Growth	-9.47%
Respiratory System Drugs	60.48M
Respiratory System Drugs Growth	4.57%
Other Drugs	60.06M
Other Drugs Growth	-55.72%
Antidepressants	56.25M
Anti-allergic Drugs	46.75M
Anti-allergic Drugs Growth	-29.34%
Other	53.05M
Other Growth	162.34%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
China	846.43M
China Growth	5.92%
Overseas	172.99K
Overseas Growth	-15.05%